Table 3 Lipid profiles and laboratory values of subjects in the placebo and α-CD groups at baseline

Safety parameters

 CRP HS (<3.0 mg/L)

1.4

0.2

 AST (9–34 U/L)

19.9

0.1

 ALT (6–41 U/L)

29.3

1.5

 TSH (0.40 − 4.00 mcIU/mL)

1.6

0.1

 Urea (8–22 mg/dL)

3.6

0.5

 Creatinine (0.56 − 1.16 mg/dL)

0.8

0.1

 Albumin (3.5 − 5.2 g/dL)

4.2

0.1

 Alk Phosp (35–105 U/L)

57.8

1.9

 Vitamin A (24–85 mcg/dL)

55.5

1.6

 Vitamin D (18–78 pg/mL)

54.5

1.7

 Vitamin E (5.0 − 19.0 mg/L)

10.9

0.5

 RBC (3.93 − 5.22 M/uL)

4.7

0.1

 WBC (3.98 − 10.04 K/uL)

5.4

0.1

Lipids and Lipoproteins

 Cholesterol (<200 mg/dL)

169.0

4.1

 Triglycerides (<150 mg/dL)

94.0

5.9

 LDL-C (<100 mg/dL)

101.0

4.0

 HDL-C (>40 mg/dL)

59.6

2.0

Glucose metabolism

 Glucose (74–106 mg/dL)

86.4

0.8

 Hgb A1C (4.0 − 6.0 %)

5.3

0.1

 Insulin (2.6 − 24.9 mcU/mL)

6.6

0.5

 LIRI^a (%, by NMR)

1.4

0.1

 HOMA IR index

1.4

0.1